European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
In a First, FDA Approves Immunotherapy Combination for Advanced Melanoma October 1, 2015December 14, 2022 Matthew Tontonoz
FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma October 30, 2015December 14, 2022 Matthew Tontonoz
FDA Approves First in a New Class of Immunotherapies October 27, 2015December 14, 2022 Matthew Tontonoz
FDA Approval Expands Immunotherapy Options for Advanced Melanoma January 27, 2016December 14, 2022 Arthur N. Brodsky, PhD
ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress June 16, 2016December 14, 2022 Arthur N. Brodsky, PhD